TY  - GEN
AU  - Gordon,A N
AU  - Stringer,C A
AU  - Matthews,C M
AU  - Willis,D L
AU  - Nemunaitis,J
TI  - Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting
SN  - 0732-183X
PY  - 1997///0616
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - CA-125 Antigen
KW  - blood
KW  - Carcinoma
KW  - Cisplatin
KW  - Disease Progression
KW  - Female
KW  - Filgrastim
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Middle Aged
KW  - Neutropenia
KW  - chemically induced
KW  - Ovarian Neoplasms
KW  - Paclitaxel
KW  - Peripheral Nervous System Diseases
KW  - Recombinant Proteins
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.1997.15.5.1965
ER  -